7 July 2021
The imminent reporting season is likely to...
6 July 2021
A takeover battle for Morrisons now overshadows the food...
Set by the government, your ISA allowance is the maximum amount you can pay into ISAs each tax year.
When you invest in the stock market, you need to strike a balance between risk and reward.
Let us help you sign in to your account.
Understand the ways to deal and how it all works.
Your account may have moved recently to OneFamily.
We answer some of the most frequently asked questions about valuation statements.
Focus on R&D should reap rewards in the second half
GSK’s deal is a bold move, allowing the company to focus on the area with real growth potential. But should investors follow GSK into the great unknown?
Consumer Healthcare units from both companies will be combined, delivering massive cost savings.
Sales are up in all areas, with expansion into emerging markets finally paying off.
Outlining an unusual way to make up your investment portfolio.
A fall in profits leads to a dip in shares as AstraZeneca updates the market.
New to investing? This is my guide on how to start.
Markets were not impressed by the latest results from BT. But is this a company that can withstand the great waves of creative disruption that are set to wash upon the technology shore.
On the day the country celebrates 70 years of the NHS, look at the current state of companies associated with healthcare and pharmaceuticals.
Ahead of the next FTSE Russell index reshuffle calculation on, we examine the most likely candidates for relegation and promotion.
While share prices collapse, some companies remain immune to the sell-off.
Income investors: for so long utilities have been seen as a haven for investors seeking income, but technology is disrupting every walk of life, and business. Are they still a haven?
House of Fraser announced 31 store closures, and Poundworld, which has now gone into administration, are just the latest examples. The high street is in crisis. There are good reasons to think it will get worse. What can investors do?
I have long been a fan of pharmaceuticals, but my patience is being stretched.
Maybe, though, not for much longer.
Britain once had an investor who was in the Warren Buffett class; his success was immense, but today he is more famous as an economist. I refer to John Maynard Keynes.
The economic recovery which looked so impressive in June is slowing, but so far so predictable. The next year will be tough, but I am sort of optimistic about the longer term.
Store closures, and declining profits; the UK high-street is in a difficult place. Can abolishing business rates help or is it delaying the inevitable downfall?
With the current crisis pushing global demand for healthcare, innovation is pushing the sector to new heights
With the coronavirus crisis continuing to ravage markets, it’s worth considering some defensive sectors that can withstand the damage
There is an approach to investing, it’s called pay yourself first. Is it something you should be doing?
Just before heading into 2020, we review the equity markets over the past year and see the top risers and fallers of 2019
With a certain 90s girl group starting their tour, our band of Investment Analysts have chosen some stocks to suit each of the distinct pop personalities
Page 1 of 1
This will also remove any price alerts you have set for this investment.